Literature DB >> 18928409

Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.

David R McGivern1, Stanley M Lemon.   

Abstract

Hepatitis C virus (HCV) is the only known RNA virus with an exclusively cytoplasmic life cycle that is associated with cancer. The mechanisms by which it causes cancer are unclear, but chronic immune-mediated inflammation and associated oxidative chromosomal DNA damage probably play a role. Compelling data suggest that the path to hepatocellular carcinoma in chronic hepatitis C shares some important features with the mechanisms of transformation employed by DNA tumor viruses. Interactions of viral proteins with key regulators of the cell cycle, the retinoblastoma-susceptibility protein, p53, and possibly DDX5 and DDX3 lead to enhanced cellular proliferation and may also compromise multiple cell-cycle checkpoints that maintain genomic integrity, thus setting the stage for carcinogenesis. Dysfunctional DNA damage and mitotic spindle checkpoints resulting from these interactions may promote chromosomal instability and leave the hepatocyte unable to control DNA damage caused by oxidative stress mediated by HCV proteins, alcohol, and immune-mediated inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18928409      PMCID: PMC4422400          DOI: 10.1146/annurev.pathol.4.110807.092202

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  117 in total

Review 1.  Internal ribosome entry site-mediated translation in hepatitis C virus replication.

Authors:  R C Rijnbrand; S M Lemon
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans.

Authors:  S M Lemon; H Lerat; S A Weinman; M Honda
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

3.  Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy.

Authors:  Christopher N Mayhew; Emily E Bosco; Sejal R Fox; Tomohisa Okaya; Pheruza Tarapore; Sandy J Schwemberger; George F Babcock; Alex B Lentsch; Kenji Fukasawa; Erik S Knudsen
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

4.  Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.

Authors:  J T Thomas; L A Laimins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Hepatitis C virus core protein interacts with a human DEAD box protein DDX3.

Authors:  A M Owsianka; A H Patel
Journal:  Virology       Date:  1999-05-10       Impact factor: 3.616

6.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

Authors:  Hervé Lerat; Masao Honda; Michael R Beard; Kim Loesch; Jiaren Sun; Yan Yang; Michiari Okuda; Rainer Gosert; Shu-Yuan Xiao; Steven A Weinman; Stanley M Lemon
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

7.  DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.

Authors:  Yasuo Ariumi; Misao Kuroki; Ken-ichi Abe; Hiromichi Dansako; Masanori Ikeda; Takaji Wakita; Nobuyuki Kato
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

8.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.

Authors:  MinKyung Yi; Rodrigo A Villanueva; David L Thomas; Takaji Wakita; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

9.  Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.

Authors:  M Gale; B Kwieciszewski; M Dossett; H Nakao; M G Katze
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

10.  Overexpression of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation.

Authors:  Kwan-Hyuck Baek; Hye-Young Park; Chang-Mo Kang; So-Jung Kim; Sook-Jung Jeong; Eun-Kyung Hong; Joong-Won Park; Young-Chul Sung; Tetsuro Suzuki; Chang-Min Kim; Chang-Woo Lee
Journal:  J Mol Biol       Date:  2006-03-29       Impact factor: 5.469

View more
  37 in total

1.  Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.

Authors:  Alessia Piluso; Laura Gragnani; Elisa Fognani; Elena Grandini; Monica Monti; Cristina Stasi; Elisabetta Loggi; Marzia Margotti; Fabio Conti; Pietro Andreone; Anna Linda Zignego
Journal:  Hepatol Int       Date:  2015-08-14       Impact factor: 6.047

2.  Unique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control.

Authors:  Christopher A Reed; Christopher N Mayhew; A Kathleen McClendon; Erik S Knudsen
Journal:  J Biol Chem       Date:  2009-11-02       Impact factor: 5.157

Review 3.  Hepatitis C and Hepatocellular Cancer: To Treat or Not to Treat.

Authors:  Renumathy Dhanasekaran; Paul Y Kwo
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

4.  DEAD-box RNA helicase Belle/DDX3 and the RNA interference pathway promote mitotic chromosome segregation.

Authors:  Jun Wei Pek; Toshie Kai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

5.  RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.

Authors:  A Kathleen McClendon; Jeffry L Dean; Adam Ertel; Zhiyan Fu; Dayana B Rivadeneira; Christopher A Reed; Ryan J Bourgo; Agnieszka Witkiewicz; Sankar Addya; Christopher N Mayhew; H Leighton Grimes; Paolo Fortina; Erik S Knudsen
Journal:  Gastroenterology       Date:  2011-06-24       Impact factor: 22.682

6.  Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation.

Authors:  Mirko Tarocchi; Rebekka Hannivoort; Yujin Hoshida; Ursula E Lee; Diana Vetter; Goutham Narla; Augusto Villanueva; Moshe Oren; Josep M Llovet; Scott L Friedman
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

7.  Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic mice.

Authors:  Mayura M Desai; Batbayar Tumurbataar; Yueqing Zhang; Lee-Nien Lillian Chan; Jiaren Sun; Teh-Sheng Chan
Journal:  Transgenic Res       Date:  2011-02-24       Impact factor: 2.788

8.  Hepatocellular carcinoma in Asia: Prevention strategy and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Afsaneh Sharifian; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-06-28

9.  RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1.

Authors:  C A Reed; C N Mayhew; A K McClendon; X Yang; A Witkiewicz; E S Knudsen
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

Review 10.  MicroRNA expression in hepatitis C virus-related malignancies: A brief review.

Authors:  Laura Gragnani; Alessia Piluso; Elisa Fognani; Anna Linda Zignego
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.